Patent · US Active

Compounds and compositions for treating conditions associated with NLRP activity

US11724992B2 · kind B2 · utility

0Cited by

4References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Luigi Franchi · Ann Arbor, US
Shomir Ghosh · Brookline, US
Gary D. Glick · Ann Arbor, US
Jason Katz · Leominster, US
Anthony Opipari · Dexter, US
William R. Roush · West Jupiter, US
Hans Martin Seidel · Concord, US
Dong-Ming Shen · Edison, US
Shankar Venkatraman · Lansdale, US
David G. Winkler · Arlington, US

Key dates

Filing date	Oct 7, 2021
Grant date	Aug 15, 2023
Priority date	—
Expiry date	Oct 7, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.